Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure

Evidence for hydroxyl radical production

Gergõ A. Molnár, Zoltán Wagner, Lajos Markó, T. Kőszegi, M. Mohás, Béla Kocsis, Z. Matus, L. Wágner, Mónika Tamaskó, István Mazák, Boglárka Laczy, J. Nagy, I. Wittmann

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background. Phenylalanine is converted to para- and orthotyrosine by hydroxyl free radical, or to para-tyrosine by the phenylalanine hydroxylase enzyme. The aim of this study was to measure para- and ortho-tyrosine in the urine and plasma of patients with chronic renal disease and/or diabetes, to obtain information on the renal handling of the different tyrosine isomers and, furthermore, to measure urinary levels of 8-epiprostaglandin-F , a marker of lipid peroxidation. Methods. In our cross-sectional study we measured para-, ortho-tyrosine, and phenylalanine levels, using high performance liquid chromatography and 8-epi-prostaglandin- F with enzyme-linked immunosorbent assay (ELISA). We compared 4 groups: (1) controls (CONTR, N = 14), (2) patients with chronic kidney disease (CKD, N = 12), (3) patients with type 2 diabetes mellitus (DIAB, N = 17), (4) patients with chronic kidney disease and type 2 diabetes (DIAB-CKD, N = 19). Results. We found a decreased plasma para-tyrosine level and decreased urinary para-tyrosine excretion in CKD patients, while the fractional excretion of para-tyrosine was similar in all 4 groups, approximately 1%. There was no difference in the plasma ortho-tyrosine levels between the groups. However, urinary ortho-tyrosine excretion was higher in all 3 groups of patients than in the CONTR group, and higher in DIAB and in DIAB-CKD patients than in CKD patients. The fractional excretion of ortho-tyrosine was significantly higher in DIAB and in DIAB-CKD patients than in the CONTR group. The fractional excretion of ortho-tyrosine exceeded 100% in the 2 diabetic groups. Urinary 8-epi-prostaglandin-F/creatinine ratio did not correlate with urinary ortho-tyrosine excretion. Conclusion. The difference between para-tyrosine levels of the groups is probably due to renal impairment, while there is indirect evidence for an increased tubular secretion or production of ortho-tyrosine in the kidney in diabetic patients with or without CKD.

Original languageEnglish
Pages (from-to)2281-2287
Number of pages7
JournalKidney International
Volume68
Issue number5
DOIs
Publication statusPublished - Nov 2005

Fingerprint

Hydroxyl Radical
Renal Insufficiency
Diabetes Mellitus
Tyrosine
Chronic Renal Insufficiency
Dinoprost
Phenylalanine
Kidney
Type 2 Diabetes Mellitus
2-tyrosine
Phenylalanine Hydroxylase
Tyrosine 3-Monooxygenase
Lipid Peroxidation
Free Radicals
Creatinine
Cross-Sectional Studies
Enzyme-Linked Immunosorbent Assay
High Pressure Liquid Chromatography
Urine
Control Groups

Keywords

  • 8-epi-prostaglandin-F
  • Chronic renal disease
  • Orthotyrosine
  • Para-tyrosine
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Nephrology

Cite this

Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure : Evidence for hydroxyl radical production. / Molnár, Gergõ A.; Wagner, Zoltán; Markó, Lajos; Kőszegi, T.; Mohás, M.; Kocsis, Béla; Matus, Z.; Wágner, L.; Tamaskó, Mónika; Mazák, István; Laczy, Boglárka; Nagy, J.; Wittmann, I.

In: Kidney International, Vol. 68, No. 5, 11.2005, p. 2281-2287.

Research output: Contribution to journalArticle

Molnár, Gergõ A. ; Wagner, Zoltán ; Markó, Lajos ; Kőszegi, T. ; Mohás, M. ; Kocsis, Béla ; Matus, Z. ; Wágner, L. ; Tamaskó, Mónika ; Mazák, István ; Laczy, Boglárka ; Nagy, J. ; Wittmann, I. / Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure : Evidence for hydroxyl radical production. In: Kidney International. 2005 ; Vol. 68, No. 5. pp. 2281-2287.
@article{caafbb2b1cc84d39a5e329a1d10d121d,
title = "Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: Evidence for hydroxyl radical production",
abstract = "Background. Phenylalanine is converted to para- and orthotyrosine by hydroxyl free radical, or to para-tyrosine by the phenylalanine hydroxylase enzyme. The aim of this study was to measure para- and ortho-tyrosine in the urine and plasma of patients with chronic renal disease and/or diabetes, to obtain information on the renal handling of the different tyrosine isomers and, furthermore, to measure urinary levels of 8-epiprostaglandin-F 2α, a marker of lipid peroxidation. Methods. In our cross-sectional study we measured para-, ortho-tyrosine, and phenylalanine levels, using high performance liquid chromatography and 8-epi-prostaglandin- F2α with enzyme-linked immunosorbent assay (ELISA). We compared 4 groups: (1) controls (CONTR, N = 14), (2) patients with chronic kidney disease (CKD, N = 12), (3) patients with type 2 diabetes mellitus (DIAB, N = 17), (4) patients with chronic kidney disease and type 2 diabetes (DIAB-CKD, N = 19). Results. We found a decreased plasma para-tyrosine level and decreased urinary para-tyrosine excretion in CKD patients, while the fractional excretion of para-tyrosine was similar in all 4 groups, approximately 1{\%}. There was no difference in the plasma ortho-tyrosine levels between the groups. However, urinary ortho-tyrosine excretion was higher in all 3 groups of patients than in the CONTR group, and higher in DIAB and in DIAB-CKD patients than in CKD patients. The fractional excretion of ortho-tyrosine was significantly higher in DIAB and in DIAB-CKD patients than in the CONTR group. The fractional excretion of ortho-tyrosine exceeded 100{\%} in the 2 diabetic groups. Urinary 8-epi-prostaglandin-F2α/creatinine ratio did not correlate with urinary ortho-tyrosine excretion. Conclusion. The difference between para-tyrosine levels of the groups is probably due to renal impairment, while there is indirect evidence for an increased tubular secretion or production of ortho-tyrosine in the kidney in diabetic patients with or without CKD.",
keywords = "8-epi-prostaglandin-F, Chronic renal disease, Orthotyrosine, Para-tyrosine, Type 2 diabetes mellitus",
author = "Moln{\'a}r, {Gerg{\~o} A.} and Zolt{\'a}n Wagner and Lajos Mark{\'o} and T. Kőszegi and M. Moh{\'a}s and B{\'e}la Kocsis and Z. Matus and L. W{\'a}gner and M{\'o}nika Tamask{\'o} and Istv{\'a}n Maz{\'a}k and Bogl{\'a}rka Laczy and J. Nagy and I. Wittmann",
year = "2005",
month = "11",
doi = "10.1111/j.1523-1755.2005.00687.x",
language = "English",
volume = "68",
pages = "2281--2287",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure

T2 - Evidence for hydroxyl radical production

AU - Molnár, Gergõ A.

AU - Wagner, Zoltán

AU - Markó, Lajos

AU - Kőszegi, T.

AU - Mohás, M.

AU - Kocsis, Béla

AU - Matus, Z.

AU - Wágner, L.

AU - Tamaskó, Mónika

AU - Mazák, István

AU - Laczy, Boglárka

AU - Nagy, J.

AU - Wittmann, I.

PY - 2005/11

Y1 - 2005/11

N2 - Background. Phenylalanine is converted to para- and orthotyrosine by hydroxyl free radical, or to para-tyrosine by the phenylalanine hydroxylase enzyme. The aim of this study was to measure para- and ortho-tyrosine in the urine and plasma of patients with chronic renal disease and/or diabetes, to obtain information on the renal handling of the different tyrosine isomers and, furthermore, to measure urinary levels of 8-epiprostaglandin-F 2α, a marker of lipid peroxidation. Methods. In our cross-sectional study we measured para-, ortho-tyrosine, and phenylalanine levels, using high performance liquid chromatography and 8-epi-prostaglandin- F2α with enzyme-linked immunosorbent assay (ELISA). We compared 4 groups: (1) controls (CONTR, N = 14), (2) patients with chronic kidney disease (CKD, N = 12), (3) patients with type 2 diabetes mellitus (DIAB, N = 17), (4) patients with chronic kidney disease and type 2 diabetes (DIAB-CKD, N = 19). Results. We found a decreased plasma para-tyrosine level and decreased urinary para-tyrosine excretion in CKD patients, while the fractional excretion of para-tyrosine was similar in all 4 groups, approximately 1%. There was no difference in the plasma ortho-tyrosine levels between the groups. However, urinary ortho-tyrosine excretion was higher in all 3 groups of patients than in the CONTR group, and higher in DIAB and in DIAB-CKD patients than in CKD patients. The fractional excretion of ortho-tyrosine was significantly higher in DIAB and in DIAB-CKD patients than in the CONTR group. The fractional excretion of ortho-tyrosine exceeded 100% in the 2 diabetic groups. Urinary 8-epi-prostaglandin-F2α/creatinine ratio did not correlate with urinary ortho-tyrosine excretion. Conclusion. The difference between para-tyrosine levels of the groups is probably due to renal impairment, while there is indirect evidence for an increased tubular secretion or production of ortho-tyrosine in the kidney in diabetic patients with or without CKD.

AB - Background. Phenylalanine is converted to para- and orthotyrosine by hydroxyl free radical, or to para-tyrosine by the phenylalanine hydroxylase enzyme. The aim of this study was to measure para- and ortho-tyrosine in the urine and plasma of patients with chronic renal disease and/or diabetes, to obtain information on the renal handling of the different tyrosine isomers and, furthermore, to measure urinary levels of 8-epiprostaglandin-F 2α, a marker of lipid peroxidation. Methods. In our cross-sectional study we measured para-, ortho-tyrosine, and phenylalanine levels, using high performance liquid chromatography and 8-epi-prostaglandin- F2α with enzyme-linked immunosorbent assay (ELISA). We compared 4 groups: (1) controls (CONTR, N = 14), (2) patients with chronic kidney disease (CKD, N = 12), (3) patients with type 2 diabetes mellitus (DIAB, N = 17), (4) patients with chronic kidney disease and type 2 diabetes (DIAB-CKD, N = 19). Results. We found a decreased plasma para-tyrosine level and decreased urinary para-tyrosine excretion in CKD patients, while the fractional excretion of para-tyrosine was similar in all 4 groups, approximately 1%. There was no difference in the plasma ortho-tyrosine levels between the groups. However, urinary ortho-tyrosine excretion was higher in all 3 groups of patients than in the CONTR group, and higher in DIAB and in DIAB-CKD patients than in CKD patients. The fractional excretion of ortho-tyrosine was significantly higher in DIAB and in DIAB-CKD patients than in the CONTR group. The fractional excretion of ortho-tyrosine exceeded 100% in the 2 diabetic groups. Urinary 8-epi-prostaglandin-F2α/creatinine ratio did not correlate with urinary ortho-tyrosine excretion. Conclusion. The difference between para-tyrosine levels of the groups is probably due to renal impairment, while there is indirect evidence for an increased tubular secretion or production of ortho-tyrosine in the kidney in diabetic patients with or without CKD.

KW - 8-epi-prostaglandin-F

KW - Chronic renal disease

KW - Orthotyrosine

KW - Para-tyrosine

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=30944444366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30944444366&partnerID=8YFLogxK

U2 - 10.1111/j.1523-1755.2005.00687.x

DO - 10.1111/j.1523-1755.2005.00687.x

M3 - Article

VL - 68

SP - 2281

EP - 2287

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -